Recurrent carpal tunnel syndrome: treatment options.
Pizzillo MF, Sotereanos DG, Tomaino MM.
J South Orthop Assoc. 1999 Spring;8(1):28-36.
Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
Correia SC, Perry G, Moreira PI.
Biochim Biophys Acta. 2016 Oct;1862(10):1909-17. doi: 10.1016/j.bbadis.2016.07.010. Epub 2016 Jul 25.
[Polyneuritis with dystrophic changes in tuberculosis of the lungs].
SVIRSKAIA ZV.
Zdravookhr Beloruss. 1962 Dec;8:64-5.
Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE, Sekhar N, Rajamma RG, Marathakam A, Al Mamun A, Uddin MS, Mathew B.
Curr Protein Pept Sci. 2020;21(12):1164-1173. doi: 10.2174/1389203721666200921152246.
Subpopulations of dystrophic neurites [correction of neuritis] in Alzheimer's brain with distinct immunocytochemical and argentophilic characteristics.
Su JH, Cummings BJ, Cotman CW.
Brain Res. 1994 Feb 21;637(1-2):37-44. doi: 10.1016/0006-8993(94)91214-9.
Neurobiology of Alzheimer's disease.
Mohandas E, Rajmohan V, Raghunath B.
Indian J Psychiatry. 2009 Jan;51(1):55-61. doi: 10.4103/0019-5545.44908.
Identification of biomarkers associated with Parkinson's disease by gene expression profiling studies and bioinformatics analysis.
Krokidis MG.
AIMS Neurosci. 2019 Dec 26;6(4):333-345. doi: 10.3934/Neuroscience.2019.4.333. eCollection 2019.
Correlative Chemical Imaging Identifies Amyloid Peptide Signatures of Neuritic Plaques and Dystrophy in Human Sporadic Alzheimer's Disease.
Koutarapu S, Ge J, Jha D, Blennow K, Zetterberg H, Lashley T, Michno W, Hanrieder J.
Brain Connect. 2023 Jun;13(5):297-306. doi: 10.1089/brain.2022.0047. Epub 2022 Oct 7.
Targeting HIF-P4H-2 in APP/PS1 Alzheimer's mouse model improves glucose metabolism, reduces dystrophic neuritis, and maintains exploratory activity.
Kurkela M, Dvořáková L, Koivisto H, Uusitalo M, Kursula P, Kettunen M, Gröhn O, Tanila H, Koivunen P.
J Biol Chem. 2025 Aug;301(8):110432. doi: 10.1016/j.jbc.2025.110432. Epub 2025 Jul 1.
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.
Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA.
Neuron. 2007 Jun 7;54(5):713-20. doi: 10.1016/j.neuron.2007.05.022.
